These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 23249712)
1. Murine infection models for vaccine development: the malaria example. Matuschewski K Hum Vaccin Immunother; 2013 Mar; 9(3):450-6. PubMed ID: 23249712 [TBL] [Abstract][Full Text] [Related]
2. Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Vaughan AM; Wang R; Kappe SH Hum Vaccin; 2010 Jan; 6(1):107-13. PubMed ID: 19838068 [TBL] [Abstract][Full Text] [Related]
3. Liver-Directed AAV8 Booster Vaccine Expressing Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S Front Immunol; 2021; 12():612910. PubMed ID: 34248928 [TBL] [Abstract][Full Text] [Related]
4. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine. Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267 [TBL] [Abstract][Full Text] [Related]
5. The march toward malaria vaccines. Hoffman SL; Vekemans J; Richie TL; Duffy PE Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116 [TBL] [Abstract][Full Text] [Related]
6. The use of transgenic parasites in malaria vaccine research. Othman AS; Marin-Mogollon C; Salman AM; Franke-Fayard BM; Janse CJ; Khan SM Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525963 [TBL] [Abstract][Full Text] [Related]
7. Vaccine candidate discovery for the next generation of malaria vaccines. Tuju J; Kamuyu G; Murungi LM; Osier FHA Immunology; 2017 Oct; 152(2):195-206. PubMed ID: 28646586 [TBL] [Abstract][Full Text] [Related]
8. The Development of Whole Sporozoite Vaccines for Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK Front Immunol; 2018; 9():2748. PubMed ID: 30619241 [TBL] [Abstract][Full Text] [Related]
9. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. Bettencourt P Front Immunol; 2020; 11():190. PubMed ID: 32153565 [No Abstract] [Full Text] [Related]
10. Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys. De SL; Stanisic DI; van Breda K; Bellete B; Harris I; McCallum F; Edstein MD; Good MF Int J Parasitol; 2016 Aug; 46(9):581-91. PubMed ID: 27238088 [TBL] [Abstract][Full Text] [Related]
11. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study. Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531 [TBL] [Abstract][Full Text] [Related]
13. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. Luke TC; Hoffman SL J Exp Biol; 2003 Nov; 206(Pt 21):3803-8. PubMed ID: 14506215 [TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum Antigen Expression in Leishmania Parasite: A Way Forward for Live Attenuated Vaccine Development. Srivastava A; Garg S; Karan S; Kaushik S; Ranganathan A; Pati S; Garg LC; Singh S Methods Mol Biol; 2022; 2410():555-566. PubMed ID: 34914067 [TBL] [Abstract][Full Text] [Related]
15. Pre-clinical and clinical development of the first placental malaria vaccine. Pehrson C; Salanti A; Theander TG; Nielsen MA Expert Rev Vaccines; 2017 Jun; 16(6):613-624. PubMed ID: 28434376 [TBL] [Abstract][Full Text] [Related]
16. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria. Mo AX; Pesce J; Hall BF Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675 [TBL] [Abstract][Full Text] [Related]
17. Vaccination With Sporozoites: Models and Correlates of Protection. Goh YS; McGuire D; Rénia L Front Immunol; 2019; 10():1227. PubMed ID: 31231377 [TBL] [Abstract][Full Text] [Related]
18. The hope but challenge for developing a vaccine that might control malaria. Good MF Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585 [TBL] [Abstract][Full Text] [Related]
19. Novel Strategies for Malaria Vaccine Design. Frimpong A; Kusi KA; Ofori MF; Ndifon W Front Immunol; 2018; 9():2769. PubMed ID: 30555463 [TBL] [Abstract][Full Text] [Related]